NCT02069717View on ClinicalTrials.gov

Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Metabolic Syndrome
Interventions
OTHER

Not applicable-observational study

Trial Locations (1)

501-757

Chonnam national university hospital, Gwangju

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY